In CRC cell lines, a correlation between invasive phenotype and high hERG1 levels of expression has been shown [11] and proliferation assays demonstrated that treating the cells with a specific hERG1 blocker (E4031) reduced tumor growth [56]. Here, KCNH2 is linked to colorectal carcinoma.